Literature DB >> 30448694

Frailty phenotype, frailty index and risk of mortality in Chinese elderly population- Rugao longevity and ageing study.

Guo-Ping Shi1, Teng Ma2, Yin-Sheng Zhu1, Zheng-Dong Wang1, Xue-Feng Chu1, Yong Wang1, Ze-Kun Chen3, Wen-Dong Xu2, Xiao-Feng Wang4, Jiang-Hong Guo5, Xiao-Yan Jiang6.   

Abstract

BACKGROUND: To explore the associations of frailty phenotype and frailty index (FI) defined frailty and pre-frailty with mortality in a Chinese elderly population.
METHODS: Data of 1788 community-dwelling elders aged 70-84 years from the ageing arm of Rugao Longevity and Ageing Study, a prospective cohort study, were used. Frailty phenotype was defined using modified Fried's phenotype (FP) criteria and FI was constructed using 45 health deficits. Mortality was ascertained using the Death Registry of Rugao's Civil Affairs Bureau.
RESULTS: During 3-year follow-up, 149 (8.3%) of the 1788 elderly subjects died. For frailty phenotype, about 9.5% of the elderly were frail and 43% were pre-frail. For FI, frail (FI > 0.21) was approximately 27.5%, and pre-frail (FI: 0.1-0.21) was approximately 51.3%. Highest mortality was observed among frail participants defined by both FP and FI criteria (all Log Rank P < 0.05). Frailty defined by the frailty index was associated with a 2.31 fold (95% CI 1.16-4.6) risk of all-cause death compared with robust elderly. Compared with the robust elderly, not only frailty (HR 2.24, 95% CI 1.31-3.83) defined by frailty phenotype but also pre-frailty (HR 1.51, 95% CI 1.03-2.21) was associated with risk of all-cause mortality.
CONCLUSIONS: Frailty, defined by either phenotype or index, is associated with increased risks of mortality in elderly Chinese community population.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Frailty index; Frailty phenotype; Pre-frailty; Prospective cohort study

Mesh:

Year:  2018        PMID: 30448694     DOI: 10.1016/j.archger.2018.11.001

Source DB:  PubMed          Journal:  Arch Gerontol Geriatr        ISSN: 0167-4943            Impact factor:   3.250


  6 in total

1.  Genetic Variants of Homocysteine Metabolism, Homocysteine, and Frailty - Rugao Longevity and Ageing Study.

Authors:  T Ma; X-H Sun; S Yao; Z-K Chen; J-F Zhang; W D Xu; X-Y Jiang; X-F Wang
Journal:  J Nutr Health Aging       Date:  2020       Impact factor: 4.075

2.  Frailty Prevalence and Association with Health-Related Quality of Life Impairment among Rural Community-Dwelling Older Adults in Vietnam.

Authors:  Anh Trung Nguyen; Long Hoang Nguyen; Thanh Xuan Nguyen; Huong Thi Thu Nguyen; Tam Ngoc Nguyen; Hai Quang Pham; Bach Xuan Tran; Carl A Latkin; Cyrus S H Ho; Roger C M Ho; Thang Pham; Huyen Thi Thanh Vu
Journal:  Int J Environ Res Public Health       Date:  2019-10-12       Impact factor: 3.390

3.  Frailty and risks of all-cause and cause-specific death in community-dwelling adults: a systematic review and meta-analysis.

Authors:  Yang Peng; Guo-Chao Zhong; Xiaoli Zhou; Lijuan Guan; Lihua Zhou
Journal:  BMC Geriatr       Date:  2022-09-02       Impact factor: 4.070

4.  Frailty index and all-cause and cause-specific mortality in Chinese adults: a prospective cohort study.

Authors:  Junning Fan; Canqing Yu; Yu Guo; Zheng Bian; Zhijia Sun; Ling Yang; Yiping Chen; Huaidong Du; Zhongxiao Li; Yulong Lei; Dianjianyi Sun; Robert Clarke; Junshi Chen; Zhengming Chen; Jun Lv; Liming Li
Journal:  Lancet Public Health       Date:  2020-12

5.  Sleep Disturbances Are Associated With Depressive Symptoms in a Chinese Population: The Rugao Longevity and Aging Cohort.

Authors:  Chunhong Qiao; Hui Zhang; Qi Song; Xi Wang; Xiaofeng Wang; Yin Yao
Journal:  Front Psychiatry       Date:  2021-12-08       Impact factor: 4.157

6.  Adherence to Healthy Lifestyle and Attenuation of Biological Aging in Middle-Aged and Older Chinese Adults.

Authors:  Junning Fan; Canqing Yu; Yuanjie Pang; Yu Guo; Pei Pei; Zhijia Sun; Ling Yang; Yiping Chen; Huaidong Du; Dianjianyi Sun; Yanjie Li; Junshi Chen; Robert Clarke; Zhengming Chen; Jun Lv; Liming Li
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2021-11-15       Impact factor: 6.053

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.